Interim report January

Q1 2026 orders fell to SEK 1,267m from SEK 1,501m, a currency-neutral decline of 6.7%, while net sales slipped 2.0% to SEK 1,257m from SEK 1,406m. Adjusted EBITA declined to SEK 117.4m from SEK 142.5m, with margin compressing to 9.3% from 10.1%, and operating profit fell to SEK 88.8m from SEK 109.2m. Net profit also decreased to SEK 45.9m from SEK 59.2m, indicating softer underlying profitability despite resilient quarterly performance.

Analysis

The key signal here is not the headline decline in sales, but that profitability is falling faster than revenue, which usually indicates a mix shift and/or operating leverage turning against the company. That matters more in a volatile FX backdrop because a mid-single-digit currency-neutral top-line deceleration can quickly become a double hit when import costs lag benefits on pricing. In other words, this is the kind of print that often looks manageable at the surface but tends to compress multiples once the market revises next-quarter margin expectations.

Second-order winners are likely to be peers with cleaner geographic exposure, stronger pricing power, or a higher share of recurring/service revenue, because buyers tend to rotate toward names where FX and demand volatility are less visible in the P&L. Suppliers with customer concentration here may also see delayed orders rather than cancellations, which is bullish for balance-sheet strength but bearish for near-term revenue visibility across the chain. If management has to defend margin by cutting discretionary spend, the impact can show up 1-2 quarters later via slower product development or weaker channel support, which often matters more than the current quarter itself.

The market is probably still underpricing duration risk: one weak quarter is not the problem, but a second sequential margin step-down would force a de-rate in a 3-6 month window. The catalyst to reverse this is either a meaningful FX tailwind or evidence that lower orders are concentrated in postponements rather than demand loss; absent that, the setup favors sell-the-rally behavior. The contrarian view is that the print may be a normalization event rather than a deterioration, especially if this company has been holding margins above cycle for several quarters; if so, the stock could stabilize once investors accept that the base has reset rather than broken.

Key Decisions for Investors

• Avoid initiating fresh longs in the stock until the next quarter confirms margin stabilization; the risk/reward is poor if operating leverage continues to deteriorate over the next 1-2 quarters.
• If liquid/shortable, consider a tactical short on strength against a basket of higher-quality peers with better pricing power and less FX sensitivity over a 1-3 month horizon; target a 2:1 downside/upside profile if margin revisions continue.
• Use any post-earnings bounce to buy put spreads 1-2 quarters out rather than outright puts; this caps premium burn while expressing the view that the next catalyst is another down revision, not an immediate collapse.
• If the company has a meaningful foreign-sales exposure, pair a long in a domestically insulated peer versus short this name to isolate FX and demand-mix risk; hold for one reporting cycle.
• Set a trigger to cover shorts if management guides to stabilization in orders or margin within the next call, since a shift from 'volatile' to 'normalizing' can re-rate the name quickly even before growth re-accelerates.